{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:41:50Z","timestamp":1794609710188,"version":"4.9.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1136\/annrheumdis-2011-201225","type":"journal-article","created":{"date-parts":[[2012,6,2]],"date-time":"2012-06-02T00:59:55Z","timestamp":1338598795000},"page":"1984-1990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"title":["Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients"],"prefix":"10.1016","volume":"71","author":[{"given":"Sebastien","family":"Viatte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Plant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bowes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Eyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Worthington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/annrheumdis-2011-201225_bib1","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1002\/art.22868","article-title":"The performance of anti-cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: results from the Norfolk Arthritis Register.","volume":"56","author":"Bukhari","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201225_bib2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/ard.2005.041376","article-title":"Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.","volume":"65","author":"Berglin","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2011-201225_bib3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/ar2384","article-title":"Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets.","volume":"10","author":"van der Helm-van Mil","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/annrheumdis-2011-201225_bib4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nrrheum.2011.28","article-title":"Rheumatoid arthritis: Are ACPA-positive and ACPA-negative RA the same disease?","volume":"7","author":"Daha","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1136\/annrheumdis-2011-201225_bib5","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1093\/rheumatology\/keq273","article-title":"Anti-citrullinated peptide antibody-negative RA is a genetically distinct subset: a definitive study using only bone-erosive ACPA-negative rheumatoid arthritis.","volume":"49","author":"Ohmura","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2011-201225_bib6","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1002\/art.21385","article-title":"Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins.","volume":"52","author":"Huizinga","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201225_bib7","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/art.24385","article-title":"Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.","volume":"60","author":"van der Woude","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201225_bib8","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1002\/art.21419","article-title":"Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles.","volume":"52","author":"Irigoyen","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201225_bib9","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/art.24410","article-title":"Opposing effects of HLA-DRB1*13 alleles on the risk of developing anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.","volume":"60","author":"Lundstr\u00f6m","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201225_bib10","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1002\/art.21302","article-title":"Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis.","volume":"52","author":"Verpoort","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201225_bib11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/art.24135","article-title":"Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region.","volume":"60","author":"Ding","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201225_bib12","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/art.27366","volume":"62","author":"van der Woude","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201225_bib13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/gene.2011.60","article-title":"A spectrum of susceptibility to rheumatoid arthritis within HLA-DRB1: stratification by autoantibody status in a large UK population.","volume":"13","author":"Mackie","year":"2012","journal-title":"Genes Immun"},{"key":"10.1136\/annrheumdis-2011-201225_bib14","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/ng.582","article-title":"Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci.","volume":"42","author":"Stahl","year":"2010","journal-title":"Nat Genet"},{"key":"10.1136\/annrheumdis-2011-201225_bib15","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/ard.2009.126821","article-title":"A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis.","volume":"70","author":"Padyukov","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2011-201225_bib16","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00296-009-1051-z","article-title":"Association between the rs7574865 polymorphism of STAT4 and rheumatoid arthritis: a meta-analysis.","volume":"30","author":"Lee","year":"2010","journal-title":"Rheumatol Int"},{"key":"10.1136\/annrheumdis-2011-201225_bib17","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/art.23549","article-title":"Association of STAT4 with rheumatoid arthritis: a replication study in three European populations.","volume":"58","author":"Orozco","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201225_bib18","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/art.23426","article-title":"Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis.","volume":"58","author":"Dieguez-Gonzalez","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201225_bib19","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/art.22704","article-title":"Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis.","volume":"56","author":"Sigurdsson","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201225_bib20","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.3899\/jrheum.080114","article-title":"Putative role of functional interferon regulatory factor 5 (IRF5) polymorphism in rheumatoid arthritis in a Korean population.","volume":"35","author":"Kim","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2011-201225_bib21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/ard.2007.085704","article-title":"A single nucleotide polymorphism in the IRF5 promoter region is associated with susceptibility to rheumatoid arthritis in the Japanese population.","volume":"68","author":"Shimane","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2011-201225_bib22","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1002\/art.24752","article-title":"Reevaluation of the interaction between HLA-DRB1 shared epitope alleles, PTPN22, and smoking in determining susceptibility to autoantibody-positive and autoantibody-negative rheumatoid arthritis in a large UK Caucasian population.","volume":"60","author":"Morgan","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201225_bib23","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1186\/ar1945","article-title":"Association of PTPN22 1858 single-nucleotide polymorphism with rheumatoid arthritis in a German cohort: higher frequency of the risk allele in male compared to female patients.","volume":"8","author":"Pierer","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/annrheumdis-2011-201225_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ajhg.2010.12.007","article-title":"Genetic basis of autoantibody positive and negative rheumatoid arthritis risk in a multi-ethnic cohort derived from electronic health records.","volume":"88","author":"Kurreeman","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1136\/annrheumdis-2011-201225_bib25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/rheumatology\/keq032","article-title":"The role of rheumatoid arthritis genetic susceptibility markers in the prediction of erosive disease in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register.","volume":"50","author":"Plant","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2011-201225_bib26","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/art.33381","article-title":"Replication of association of the PTPRC gene with response to anti-tumor necrosis factor therapy in a large UK cohort","volume":"64","author":"Plant","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201225_bib27","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature05911","article-title":"Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls","volume":"447","year":"2007","journal-title":"Nature"},{"key":"10.1136\/annrheumdis-2011-201225_bib28","doi-asserted-by":"crossref","first-page":"R180","DOI":"10.1186\/ar3505","article-title":"Can anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes?","volume":"13","author":"De Rooy","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/annrheumdis-2011-201225_bib29","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1146\/annurev.immunol.26.021607.090244","article-title":"Immunity to citrullinated proteins in rheumatoid arthritis.","volume":"26","author":"Klareskog","year":"2008","journal-title":"Annu Rev Immunol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724185986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724185986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/annrheumdis-2011-201225","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T08:42:37Z","timestamp":1739522557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724185986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0003496724185986"],"URL":"https:\/\/doi.org\/10.1136\/annrheumdis-2011-201225","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2011-201225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier Inc. For permission to use (where not already granted under a licence) please go to http:\/\/group.bmj.com\/group\/rights-licensing\/permissions. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}